TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
Thumbnail

AI model predicts diabetes risk using MRI results

The algorithm measures the amount of fat surrounding a person's heart, using that information to create an accurate diabetes risk assessment. 

Thumbnail

TAVR safe for patients with inflammatory bowel disease

Patients with Crohn’s disease and ulcerative colitis can safely undergo TAVR, researchers at the Cleveland Clinic have confirmed in a new analysis.

Permanent pacemaker implantation before or after TAVR linked to worse outcomes

Researchers tracked more than 49,000 TAVR patients, sharing their findings in Heart Rhythm. 

Thumbnail

Florida hospital celebrates 100th TAVR procedure

The procedure, like the hospital's first 99 TAVR cases, was a success. 

Thumbnail

Valve-in-valve TAVR outcomes ‘excellent’ after one year

Moderate to severe aortic regurgitation was seen in 0.9% of patients after 30 days and 1.3% after one year.

Tai chi could help ease depression, anxiety among stroke survivors

An eight-week tai chi course provided key benefits for older stroke survivors, researchers reported. 

How predilation affects TAVR outcomes for low-risk patients

The new study, published in Circulation: Cardiovascular Interventions, included data from nearly 500 TAVR patients.

Thumbnail

To delay or not to delay? When treating TAVR patients during the pandemic, heart teams faced big decisions

Delaying TAVR for six months can have a negative effect on patient outcomes. During the pandemic, however, there were certain times when a delay was safer than completing the procedure. 

Displaying 345 - 352 of 424

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.